Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or over (men or women) who have been diagnosed with a blockage or narrowing of the arteries in their legs, confirmed by an ultrasound or imaging scan of the blood vessels.
Who may not be able to join:
- People under 18 years of age.
- People who have had a severe allergic reaction (anaphylaxis) in the past.
- People who have a known allergy or sensitivity to any ingredient in the study drug Slavinorm®, or to proteins derived from animals.
- People who have a medical reason that prevents them from safely doing a treadmill walking test.
- People who are unable to walk on a treadmill at a slow speed (3.2 km/h) on a low incline for at least 2 minutes during the initial screening test.
- People whose heart shows a particular abnormal pattern on an ECG (heart tracing) during the treadmill test (confirm with trial site).
- People whose leg artery disease is caused by something other than a buildup of fatty deposits in the arteries (atherosclerosis).
- People who have had surgery or a procedure on the arteries in their legs but do not experience leg pain or cramping when walking.
- People with severe chest pain (angina) classified as Class III or IV by their heart specialist.
- People with a body weight that places their Body Mass Index (BMI) above 35 kg/m².
- People with serious kidney problems (where the kidneys are filtering at a reduced rate) or serious liver problems (where certain liver enzyme levels are significantly elevated).
- People with severe heart failure, classified as Class III or IV by their doctor.
- People who have had a heart attack or a serious heart event within the 6 months before the start of the trial screening period.
- People with any other significant health condition that, in the opinion of the trial doctor, would make participation unsafe or unsuitable.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Igor Suchkov, Ryazan State Medical University
Phone: 8-903-836-24-17
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Lower artery or bypass graft thrombosis; disease progression; restenosis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.